Actively Recruiting

Phase 1
Age: 18Years +
All Genders
Healthy Volunteers
NCT05774717

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Led by Vanderbilt University Medical Center · Updated on 2026-05-07

60

Participants Needed

1

Research Sites

313 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will be a prospective randomized study to evaluate the effect of tranexamic acid (TXA) use on intraoperative and postoperative outcomes among patients undergoing rhinoplasty by two Facial Plastic surgeons at Vanderbilt. Outcomes will include intra- and post-operative bleeding and postoperative bruising and swelling.

CONDITIONS

Official Title

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults at least 18 years of age who elect to undergo cosmetic or functional open primary rhinoplasty with osteotomies by Drs. Yang or Patel at VUMC
  • No other facial plastic or sinus surgery performed at the same time
  • Must not meet any of the exclusion criteria
Not Eligible

You will not qualify if you...

  • Known allergy to tranexamic acid (TXA)
  • Intracranial bleeding
  • Known defective color vision
  • History of venous or arterial thromboembolism
  • Active thromboembolic disease
  • Severe renal impairment (chronic kidney disease)
  • History of coagulation disorder
  • Known thrombocytopenia (platelets less than 150,000)
  • Current use of anticoagulant medication
  • Uncontrolled diabetes mellitus preventing use of dexamethasone perioperatively
  • Cardiac arrhythmia
  • History of acute myocardial infarction, stroke, seizure, or liver failure
  • Laboratory values showing platelets less than 150,000, prothrombin time greater than 45, INR greater than 1.2, or seizure disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

Loading map...

Research Team

S

Shiayin F Yang, MD

CONTACT

J

Jaclyn Lee, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here